Literature DB >> 25547317

Dopamine transporter gene may be associated with bipolar disorder and its personality traits.

Chang-Chih Huang1, Ru-Band Lu, Che-Hung Yen, Yi-Wei Yeh, Han-Wei Chou, Shin-Chang Kuo, Chun-Yen Chen, Chuan-Chia Chang, Hsin-An Chang, Pei-Shen Ho, Chih-Sung Liang, Serena Cheng, Mei-Chen Shih, San-Yuan Huang.   

Abstract

Dopamine transporter and its genetic factors have been suggested to play a critical role in the development of bipolar disorder (BPD). However, the importance of the dopamine transporter gene (DAT1) in the pathogenesis of BPD remains unclear. The aims of this study were to assess 18 polymorphisms of the DAT1 gene to determine whether this gene is associated with BPD and whether it influences personality traits of patients with BPD. DAT1 polymorphisms were analyzed in 492 BPD (374 BPDI and 118 BPDII) patients and 436 controls. All participants were screened using the same assessment tool, and all met the criteria for BPD. The Tridimensional Personality Questionnaire was used to assess personality traits in both patients and controls. Several polymorphisms had a weak association with BPD, including rs2550948, rs2652511, and rs2975226 in allele distribution analysis (P < 0.05). Furthermore, the promoter G-A-C-G haplotype (rs6350-rs2975226-rs2652511-rs6413429) was over-represented in the BPD patients compared to the controls (P = 0.007). In personality assessment, the BPDII patients had the highest harm avoidance score, followed by the BPDI patients and controls (P = 3.7 × 10(-32)). In addition, a significant association between rs40184 and harm avoidance was found in the patients with BPD. The DAT1 promoter may be associated with vulnerabilities in BPD. The BPD patients had a higher rate of harm avoidance personality traits than the controls, and DAT1 variants may influence personality traits in patients with BPD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547317     DOI: 10.1007/s00406-014-0570-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  51 in total

1.  Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.

Authors:  John F Cryan; Daniel Hoyer; Athina Markou
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

2.  A common haplotype at the dopamine transporter gene 5' region is associated with attention-deficit/hyperactivity disorder.

Authors:  Júlia P Genro; Guilherme V Polanczyk; Cristian Zeni; Angélica S Oliveira; Tatiana Roman; Luis A Rohde; Mara H Hutz
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

3.  Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease.

Authors:  Samir N Kelada; Paola Costa-Mallen; Harvey Checkoway; Christopher S Carlson; Terri-Smith Weller; Phillip D Swanson; Gary M Franklin; W T Longstreth; Zahra Afsharinejad; Lucio G Costa
Journal:  Pharmacogenet Genomics       Date:  2005-09       Impact factor: 2.089

4.  Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1.

Authors:  Ting Ting Chang; Tzung Lieh Yeh; Nan Tsing Chiu; Po See Chen; Hsiang Yu Huang; Yen Kuang Yang; I Hui Lee; Ru Band Lu
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

Review 5.  Atypical antipsychotics for bipolar disorder.

Authors:  Lakshmi N Yatham
Journal:  Psychiatr Clin North Am       Date:  2005-06

6.  Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.

Authors:  T A Greenwood; N J Schork; E Eskin; J R Kelsoe
Journal:  Mol Psychiatry       Date:  2006-02       Impact factor: 15.992

7.  Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder.

Authors:  Julia K Pinsonneault; Dawn D Han; Katherine E Burdick; Maria Kataki; Alessandro Bertolino; Anil K Malhotra; Howard H Gu; Wolfgang Sadee
Journal:  Neuropsychopharmacology       Date:  2011-04-27       Impact factor: 7.853

8.  Association and linkage of allelic variants of the dopamine transporter gene in ADHD.

Authors:  S Friedel; K Saar; S Sauer; A Dempfle; S Walitza; T Renner; M Romanos; C Freitag; C Seitz; H Palmason; A Scherag; C Windemuth-Kieselbach; B G Schimmelmann; C Wewetzer; J Meyer; A Warnke; K P Lesch; R Reinhardt; B Herpertz-Dahlmann; M Linder; A Hinney; H Remschmidt; H Schäfer; K Konrad; N Hübner; J Hebebrand
Journal:  Mol Psychiatry       Date:  2007-04-10       Impact factor: 15.992

Review 9.  The role of dopamine in bipolar disorder.

Authors:  David A Cousins; Kelly Butts; Allan H Young
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

10.  Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD.

Authors:  Kaixin Zhou; Wai Chen; Jan Buitelaar; Tobias Banaschewski; Robert D Oades; Barbara Franke; Edmund Sonuga-Barke; Richard Ebstein; Jacques Eisenberg; Michael Gill; Iris Manor; Ana Miranda; Fernando Mulas; Herbert Roeyers; Aribert Rothenberger; Joseph Sergeant; Hans-Christoph Steinhausen; Jessica Lasky-Su; Eric Taylor; Keeley J Brookes; Xiaohui Xu; Benjamin M Neale; Fruhling Rijsdijk; Margaret Thompson; Philip Asherson; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

View more
  10 in total

1.  Classification and neurobiological concepts of mania, bipolar disorder and major depression.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-06       Impact factor: 5.270

2.  Candidate gene associations studies in psychiatry: time to move forward.

Authors:  C Arango
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-02       Impact factor: 5.270

3.  Whole-brain mapping of socially isolated zebrafish reveals that lonely fish are not loners.

Authors:  Hande Tunbak; Mireya Vazquez-Prada; Thomas Michael Ryan; Adam Raymond Kampff; Elena Dreosti
Journal:  Elife       Date:  2020-05-05       Impact factor: 8.140

4.  A Meta-analysis of the Association Between SLC6A3 Gene Polymorphisms and Schizophrenia.

Authors:  Feng-Ling Xu; Mei Ding; Xue Wu; Yong-Ping Liu; Xi Xia; Jun Yao; Bao-Jie Wang
Journal:  J Mol Neurosci       Date:  2019-08-22       Impact factor: 3.444

5.  Association analyses reveal gender-specific associations of DAT1 40-bp VNTR and -839C/T polymorphisms with obsessive-compulsive disorder and obsessive-compulsive symptoms.

Authors:  Juliana C Cotrin; Leonardo F Fontenelle; Fabiana B Kohlrausch
Journal:  Mol Biol Rep       Date:  2019-07-19       Impact factor: 2.316

6.  The SLC6A3 gene possibly affects susceptibility to late-onset alcohol dependence but not specific personality traits in a Han Chinese population.

Authors:  Chang-Chih Huang; Shin-Chang Kuo; Yi-Wei Yeh; Chun-Yen Chen; Che-Hung Yen; Chih-Sung Liang; Pei-Shen Ho; Ru-Band Lu; San-Yuan Huang
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

7.  Short-active photoperiod gestation induces psychiatry-relevant behavior in healthy mice but a resiliency to such effects are seen in mice with reduced dopamine transporter expression.

Authors:  Molly A Kwiatkowski; Zackary A Cope; Maria L Lavadia; Chuck J A van de Cappelle; Davide Dulcis; Jared W Young
Journal:  Sci Rep       Date:  2020-06-23       Impact factor: 4.379

8.  Presence of recombination hotspots throughout SLC6A3.

Authors:  Juan Zhao; Yanhong Zhou; Nian Xiong; Hong Qing; Tao Wang; Zhicheng Lin
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

9.  Evaluation of VNTR polymorphisms of dopamine transporter gene and the risk of bipolar disorder in Zahedan, southeast Iran.

Authors:  Mansour Shakiba; Mohammad Hashemi; Salah Mahdar; Zahra Rahbari; Gholamreza Bahari
Journal:  Mol Biol Res Commun       Date:  2017-09

10.  Dysregulation of oxytocin and dopamine in the corticostriatal circuitry in bipolar II disorder.

Authors:  Shyh-Yuh Wei; Huai-Hsuan Tseng; Hui Hua Chang; Tsung-Hua Lu; Wei Hung Chang; Nan Tsing Chiu; Yen Kuang Yang; Po See Chen
Journal:  Transl Psychiatry       Date:  2020-08-12       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.